FindTrial
Sign In

Correlation Analysis of IL-6 Trans-Signaling Pathway-Related Molecules with Disease Severity and Clinical Outcomes in Sepsis Patients with Cardiac Dysfunction

Correlation Analysis of IL-6 Trans-Signaling Pathway-Related Molecules with Disease Severity and Clinical Outcomes in Sepsis Patients with Cardiac Dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108197
Enrollment
Unknown
Registered
2025-08-26
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Non-sepsis group:None
Sepsis group:None
Sepsis-induced cardiac dysfunction group:None

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Critically ill adults aged =18 years. 2 Patients in the sepsis and sepsis-induced cardiac dysfunction groups met the Sepsis-3 diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1 Patients with incomplete medical records 2 Patients with pre-existing coronary artery disease or heart failure 3 Autoimmune diseases 4 Hematological disorders 5 Malignancies 6 Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
IL-6;sIL-6R;sgp130;—

Countries

China

Contacts

Public ContactLiu Xuefang

The Second Hospital of Hebei Medical University

28604110@hebmu.edu.cn+86 159 3168 6132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026